Market News
ICICI Bank, Bajaj Finance and Sun Pharma delivered consistent profit growth for last four quarters
.png)
5 min read | Updated on September 02, 2024, 14:03 IST
SUMMARY
ICICI Bank, Bajaj Finance and Sun Pharma showcase consistent growth, attracting investors confidence. Their strong fundamentals and long-term potential make them solid picks for sustained value.
Stock list
ICICI Bank, Bajaj Finance and Sun Pharma have delivered consistent growth
Consistent profit and revenue growth are important for companies as they indicate financial stability, efficient management, efficient business strategies and market competitiveness.
A consistently increasing earnings growth rate over several periods signifies the company’s ability to generate higher profits. This trend often attracts investors seeking stability and potential returns. Companies with strong earnings growth rates might outperform their peers in the market, attracting investor attention and potentially leading to increased stock prices.
Here are the top 3 stocks with consistent profit and revenue growth by market capitalisation.
ICICI Bank Ltd (Current price ₹1,230)
The lender’s current market cap stands at ₹8,65,529 crore, the bank has delivered good profit growth of 59.7% CAGR over the last 5 years. During the Q1FY25, total period-end deposits grew by 17.9% YoY to ₹ 12,38,737 crore, total period-end deposits grew by 17.9% YoY to ₹12,38,737 crore and the average CASA ratio remained at 42.6% in the quarter.
The following table represents previous quarters’ revenue and profit and their growth on a year-on-year (YoY) and quarter-on-quarter (QoQ) basis. (Amount in ₹ crore)
| Month | Sep-23 | Dec-23 | Mar-24 | Jun-24 |
|---|---|---|---|---|
| Revenue | 38,938 | 40,865 | 42,607 | 44,582 |
| YoY Growth | 34.97% | 29.24% | 23.72% | 20.15% |
| QoQ Growth | 4.94% | 4.95% | 4.26% | 4.64% |
| Net Profit | 11,351 | 11,515 | 12,200 | 12,463 |
| YoY Growth | 35.76% | 25.63% | 19.19% | 13.16% |
| QoQ Growth | 3.06% | 1.44% | 5.95% | 2.16% |
Bajaj Finance Ltd (Current price ₹7,427)
Bajaj Finance's current market cap stands at ₹4,60,186 crore, it has delivered good profit growth of 29.4% CAGR over the last 5 years. During Q1, AUM was up 31% at ₹ 3,54,192 crore, cost of funds was 7.94%, an increase of 8 bps over QoQ basis. The Deposit book grew by 26% YoY and stood at ₹ 62,774 crore. Deposits contributed to 20% of consolidated borrowings as of 30 June 2024.
Following table represents previous quarters’ revenue and profit and their growth on a YoY and QoQ basis. (Amount in ₹ crore)
| Month | Sep-23 | Dec-23 | Mar-24 | Jun-24 |
|---|---|---|---|---|
| Revenue | 13,378 | 14,164 | 14,926 | 16,099 |
| YoY Growth | 34.18% | 31.31% | 31.34% | 28.81% |
| QoQ Growth | 7.04% | 5.88% | 5.38% | 7.86% |
| Net Profit | 3,551 | 3,639 | 3,825 | 3,912 |
| YoY Growth | 27.69% | 22.40% | 21.12% | 13.82% |
| QoQ Growth | 3.32% | 2.48% | 5.11% | 2.27% |
Sun Pharmaceuticals Industries Ltd (Current price ₹1,812)
The pharma major’s current market cap stands at ₹4,33,068 crore, it has delivered a good profit growth of 23.4% CAGR over the last 5 years and maintained a healthy dividend payout of 46.6%. Sun Pharma is ranked No. 1 with a market share of 8.6% in ₹2,019 billion Indian pharmaceutical market as per AIOCD AWACS MAT June-2024 report.
Following table represents previous quarters' revenue and profit and their growth on YoY and QoQ basis (Amount in ₹ crore).
| Month | Sep-23 | Dec-23 | Mar-24 | Jun-24 |
|---|---|---|---|---|
| Revenue | 12,192 | 12,381 | 11,983 | 12,653 |
| YoY Growth | 11.32% | 10.14% | 9.62% | 5.96% |
| QoQ Growth | 2.10% | 1.55% | -3.21% | 5.59% |
| Net Profit | 2,385 | 2,561 | 2,659 | 2,861 |
| YoY Growth | 5.72% | 17.42% | 34.09% | 42.62% |
| QoQ Growth | 18.89% | 7.38% | 3.83% | 7.60% |
Conclusion
ICICI Bank, Bajaj Finance and Sun Pharma have consistently delivered strong revenue and profit growth, backed by robust market position. Their impressive CAGRs highlight their potential for sustained performance and long-term value.
About The Author
Next Story
